Search research articles
Contact Us
Filters
Showing results (241-250 of 403) with videos related to
Page
of 41
Sort By:
The Journal of Infection
|
September 9, 2023
Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England
Stephen A Clark, Helen Campbell, Sonia Ribeiro, et al.
Clinical and Diagnostic Laboratory Immunology
|
August 9, 2005
Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine
Ray Borrow, Ingeborg S Aaberge, George F Santos, et al.
Vaccine
|
August 21, 2007
Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005
Mehmet Ceyhan, Inci Yildirim, Paul Balmer, et al.
Plos One
|
May 31, 2018
Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines
Caroline Cayrou, Ayodeji A Akinduko, Evgeny M Mirkes, et al.
Diagnostic Microbiology and Infectious Disease
|
June 15, 2025
Interlaboratory study to assess precision and reproducibility of the meningococcal antigen surface expression (MEASURE) assay to quantify factor H binding protein expression at the surface of meningococcal serogroup B strains
Jakob Loschko, Paul Liberator, Jamie Findlow, et al.
Human Vaccines
|
September 2, 2008
Immune response to pneumococcal conjugate vaccination in asplenic individuals
Elaine Stanford, Fiona Print, Michelle Falconer, et al.
The Journal of Infectious Diseases
|
December 30, 2015
The Interleukin-1 Balance During Encephalitis Is Associated With Clinical Severity, Blood-Brain Barrier Permeability, Neuroimaging Changes, and Disease Outcome
Benedict Daniel Michael, Michael J Griffiths, Julia Granerod, et al.
Clinical and Vaccine Immunology : CVI
|
August 9, 2006
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?
Theodore F Tsai, Ray Borrow, Hanspeter E Gnehm, et al.
Clinical and Vaccine Immunology : CVI
|
June 28, 2013
Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamica
Jay Lucidarme, Stefanie Gilchrist, Lynne S Newbold, et al.
Clinical and Vaccine Immunology : CVI
|
April 9, 2010
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine
Jay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
Page
of 41
Search research articles
Search
Showing results (241-250 of 403) with videos related to
Sort By:
Page
of 41
The Journal of Infection
|
September 9, 2023
Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England
Stephen A Clark, Helen Campbell, Sonia Ribeiro, et al.
Clinical and Diagnostic Laboratory Immunology
|
August 9, 2005
Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine
Ray Borrow, Ingeborg S Aaberge, George F Santos, et al.
Vaccine
|
August 21, 2007
Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005
Mehmet Ceyhan, Inci Yildirim, Paul Balmer, et al.
Plos One
|
May 31, 2018
Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines
Caroline Cayrou, Ayodeji A Akinduko, Evgeny M Mirkes, et al.
Diagnostic Microbiology and Infectious Disease
|
June 15, 2025
Interlaboratory study to assess precision and reproducibility of the meningococcal antigen surface expression (MEASURE) assay to quantify factor H binding protein expression at the surface of meningococcal serogroup B strains
Jakob Loschko, Paul Liberator, Jamie Findlow, et al.
Human Vaccines
|
September 2, 2008
Immune response to pneumococcal conjugate vaccination in asplenic individuals
Elaine Stanford, Fiona Print, Michelle Falconer, et al.
The Journal of Infectious Diseases
|
December 30, 2015
The Interleukin-1 Balance During Encephalitis Is Associated With Clinical Severity, Blood-Brain Barrier Permeability, Neuroimaging Changes, and Disease Outcome
Benedict Daniel Michael, Michael J Griffiths, Julia Granerod, et al.
Clinical and Vaccine Immunology : CVI
|
August 9, 2006
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?
Theodore F Tsai, Ray Borrow, Hanspeter E Gnehm, et al.
Clinical and Vaccine Immunology : CVI
|
June 28, 2013
Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamica
Jay Lucidarme, Stefanie Gilchrist, Lynne S Newbold, et al.
Clinical and Vaccine Immunology : CVI
|
April 9, 2010
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine
Jay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
Page
of 41